-
Mashup Score: 6
In a new study, scientists at Dana-Farber and others have identified a small molecule that interacts with BAX in a way that alters BAX’s activity.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11
Follicular lymphoma is a slow-growing form of non-Hodgkin lymphoma (NHL) that arises in white blood cells called B lymphocytes.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10Boston Marathon Run is Mother-Daughter Moment for Breast and Uterine Cancer Survivor | Dana-Farber Cancer Institute - 25 day(s) ago
Published: April 12, 2024Written by: Saul WisniaRunners call it Heartbreak Hill, but for Michelle O’Brien the long, rising stretch of pavement that crosses the 20-mile point of the Boston Marathon® route represents the top of the mountain. Just over three years after being diagnosed in back-to-back months with two unrelated cancers — invasive breast cancer … Read more
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
BCL2 inhibitors are drugs that prompt cancer cells to die by altering the interactions among key proteins within the cells.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0A Patient-Doctor Bond Forged in Fighting Follicular Lymphoma | Dana-Farber Cancer Institute - 27 day(s) ago
Along with his wife, Lorna, one individual has been there for Robert Jenkins nearly every step of the way: his oncologist Eric Jacobsen, MD.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Patient with Breast Cancer Lives Her Best Life with the Help of a Team | Dana-Farber Cancer Institute - 28 day(s) ago
Dana-Farber’s Program for Older Adults with Breast Cancer was created for patients like Vici Robinson to ensure that they can live fulfilling lives.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 12Still Swimming with Sharks After Inflammatory Breast Cancer | Dana-Farber Cancer Institute - 29 day(s) ago
As a veteran scuba diver who has donned her wetsuit around the globe, Stephanie Lafontaine is never more at peace than when deep below the water’s surface.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
CAR T-cell therapy is a form of immunotherapy that uses specially modified T cells — part of the body’s defense system against disease — to attack cancer.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13Young Mother with Lynch Syndrome Doing Well on Immunotherapy | Dana-Farber Cancer Institute - 1 month(s) ago
Shortly after Stephanie Dobson’s rectal cancer diagnosis, she and her husband met with Dana-Farber’s Matthew Yurgelun, MD, who already had a plan.
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7Cancer Rates Are Increasing in People Under 50: How to Manage Your Risk | Dana-Farber Cancer Institute - 1 month(s) ago
Published: December 13, 2022Updated: February 21, 2023Written by: Rob LevyMedically Reviewed By: Timothy Richard Rebbeck, PhDMost commonly occurring cancers are diagnosed in people over age 50. Over the past several decades, however, rates of many types of cancer have been rising in adults under 50. Reports suggest that these include breast, colorectal, endometrial, esophageal, bile … Read more
Source: blog.dana-farber.orgCategories: General Medicine News, Onc News and JournalsTweet
Loren Walensky, MD, PhD, has dedicated nearly two decades of research to the protein BAX, highlighting its potential in cancer therapy. https://t.co/8HUXuhRbvW